Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol (Q44264675)

1 December 2017

title

Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol (English)

1 reference

1 December 2017

2

Murat Kuloglu

1 reference

1 December 2017

1

Murad Atmaca

1 reference

1 December 2017

5

Omer Gecici

1 reference

1 December 2017

3

Ertan Tezcan

1 reference

1 December 2017

Halit Canatan

4

1 reference

1 December 2017

publication date

1 November 2002

1 reference

Archives of Medical Research

1 December 2017

published in

1 reference

1 December 2017

volume

33

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

562-565

1 reference

The Lateral and Medial Median Eminence: Distribution of Dopamine, Norepinephrine, and Luteinizing Hormone-Releasing Hormone and the Effect of Prolactin on Catecholamine Turnover*

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Neuroleptic-induced hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Clozapine: plasma levels and prolactin response

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Clozapine does not elevate serum prolactin levels in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Prolactin and antipsychotic medications: mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2802%2900403-4

7 January 2021

10.1016/S0188-4409(02)00403-4

Identifiers

DOI

1 reference

1 December 2017

1 reference